These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33506689)

  • 1. Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao RL; Li JJ
    J Am Heart Assoc; 2021 Feb; 10(3):e018869. PubMed ID: 33506689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Invasive Liver Fibrosis Scores Are Associated With Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
    He HM; He C; You ZB; Zhang SC; Lin XQ; Luo MQ; Lin MQ; Zhang LW; Lin KY; Guo YS
    Angiology; 2023 Apr; 74(4):333-343. PubMed ID: 35642134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention.
    Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Xu RX; Chen XH; Li JJ
    J Am Heart Assoc; 2020 Feb; 9(3):e014581. PubMed ID: 32013705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction.
    Cao Y; Guo S; Dong Y; Liu C; Zhu W
    ESC Heart Fail; 2023 Jun; 10(3):1771-1780. PubMed ID: 36864701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
    Xiong S; Yin S; Deng W; Zhao Y; Li W; Wang P; Li Z; Yang H; Zhou Y; Yu S; Guo X; Sun Y
    J Hypertens; 2023 May; 41(5):741-750. PubMed ID: 36883472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of liver fibrosis score on the incidence of stroke: A cohort study.
    Xiong S; Yin S; Deng W; Zhao Y; Li W; Wang P; Li Z; Yang H; Zhou Y; Yu S; Guo X; Sun Y
    Liver Int; 2022 Oct; 42(10):2175-2185. PubMed ID: 35789194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
    J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
    Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study.
    Cao YX; Zhang M; Zhang HW; Jin JL; Liu HH; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Dong Q; Sun J; Li JJ
    Liver Int; 2021 Jun; 41(6):1294-1304. PubMed ID: 33389804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
    Chen Q; Li Q; Li D; Chen X; Liu Z; Hu G; Wang J; Ling W
    Atherosclerosis; 2020 Apr; 299():45-52. PubMed ID: 32240838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of disturbed sleep predict major adverse cardiac events after percutaneous coronary intervention.
    Fernandes NM; Nield LE; Popel N; Cantor WJ; Plante S; Goldman L; Prabhakar M; Manlhiot C; McCrindle BW; Miner SE
    Can J Cardiol; 2014 Jan; 30(1):118-24. PubMed ID: 24140074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedure-related bleeding in elective percutaneous coronary interventions.
    Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
    Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.
    Lu Y; Zhang H; Wang Y; Zhou T; Welsh J; Liu J; Guan W; Li J; Li X; Zheng X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    JAMA Netw Open; 2018 Dec; 1(8):e185446. PubMed ID: 30646292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.
    Grodzinsky A; Kosiborod M; Tang F; Jones PG; McGuire DK; Spertus JA; Beltrame JF; Jang JS; Goyal A; Butala NM; Yeh RW; Arnold SV
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28904076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the Framingham Risk Score in predicting secondary events in patients following percutaneous coronary intervention: A time-trend analysis.
    Sara JD; Lennon RJ; Gulati R; Singh M; Holmes DR; Lerman LO; Lerman A
    Am Heart J; 2016 Feb; 172():115-28. PubMed ID: 26856223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
    Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of nutritional status assessed by the Controlling Nutritional Status score in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Wada H; Dohi T; Miyauchi K; Doi S; Konishi H; Naito R; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Clin Res Cardiol; 2017 Nov; 106(11):875-883. PubMed ID: 28634674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
    Song DS; Chang UI; Kang SG; Song SW; Yang JM
    Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
    Chen Y; Yin T; Xi S; Zhang S; Yan H; Tang Y; Qian J; Chen J; Su X; Du Z; Wang L; Qin Q; Gao C; Zheng Y; Zhao X; Cheng X; Li Z; Zhang W; Chen H; Wang J; Yang Z; Li H; Liu H; Zhou X; Qu B; Xiang D; Guo Y; Wang L; Nie S; Fu G; Yang M; Cai S
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1194-1204. PubMed ID: 31112635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.